Clinical trial
The Effects of OMACOR on the LDL Sub-fraction in Korean Type 2 Diabetic Patients With Combined Hyperlipidemia
NCT00758927 is registered in ClinicalTrials.gov with Inje University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effects of OMACOR on the LDL Sub-fraction in Korean Type 2 Diabetic Patients With Combined Hyperlipidemia
- Lead sponsor
- Inje University
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- July 31, 2009
- Completion date
- July 31, 2010
- Enrollment
- 70 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.